These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24839329)
21. The use of cost-effectiveness analysis for pediatric immunization in developing countries. Gauvreau CL; Ungar WJ; Köhler JC; Zlotkin S Milbank Q; 2012 Dec; 90(4):762-90. PubMed ID: 23216430 [TBL] [Abstract][Full Text] [Related]
22. Can we use contingent valuation to assess the demand for childhood immunisation in developing countries?: a systematic review of the literature. Yeung RY; Smith RD Appl Health Econ Health Policy; 2005; 4(3):165-73. PubMed ID: 16309334 [TBL] [Abstract][Full Text] [Related]
23. Examining the cost of delivering routine immunization in Honduras. Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175 [TBL] [Abstract][Full Text] [Related]
24. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030. Sim SY; Watts E; Constenla D; Huang S; Brenzel L; Patenaude BN Value Health; 2021 Jan; 24(1):70-77. PubMed ID: 33431156 [TBL] [Abstract][Full Text] [Related]
25. Strengthening global vaccine access for adolescents and adults. Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384 [TBL] [Abstract][Full Text] [Related]
26. [The Expanded Programme on Immunization: the results of its realization, problems and outlook]. Litvinov SK; Henderson RH; Galazka AM; Lobanov AV Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):114-20. PubMed ID: 3887812 [No Abstract] [Full Text] [Related]
27. [The World Health Organization and the problem of elimination of infectious diseases in the world]. Seĭbil' VB; Malyshkina LP Vopr Virusol; 2005; 50(3):60-4. PubMed ID: 16078437 [No Abstract] [Full Text] [Related]
33. 500m dollars investment in poor countries' health systems will boost vaccination. Zarocostas J BMJ; 2007 Feb; 334(7587):225. PubMed ID: 17272541 [No Abstract] [Full Text] [Related]
34. Sustainable introduction of affordable new vaccines: the targeting strategy. Batson A Vaccine; 1998 Nov; 16 Suppl():S93-8. PubMed ID: 9915047 [TBL] [Abstract][Full Text] [Related]
35. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi. Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006 [TBL] [Abstract][Full Text] [Related]
36. Can investments in health systems strategies lead to changes in immunization coverage? Brenzel L Expert Rev Vaccines; 2014 Apr; 13(4):561-72. PubMed ID: 24588785 [TBL] [Abstract][Full Text] [Related]
37. [Vaccination programs between individual autonomy and common welfare]. Marckmann G Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Feb; 51(2):175-83. PubMed ID: 18227984 [TBL] [Abstract][Full Text] [Related]
38. Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policy. Coleman MS; Washington ML; Orenstein WA; Gazmararian JA; Prill MM Epidemiol Rev; 2006; 28():41-6. PubMed ID: 16740584 [TBL] [Abstract][Full Text] [Related]
39. Economic analysis of the vaccination strategies adopted in Brazil in 1982. Domínguez Ugá MA Bull Pan Am Health Organ; 1988; 22(3):250-68. PubMed ID: 3147117 [No Abstract] [Full Text] [Related]
40. Did you get your shots? Experimental evidence on the role of reminders. Busso M; Cristia J; Humpage S J Health Econ; 2015 Dec; 44():226-37. PubMed ID: 26519909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]